Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 82, 2022 - Issue 1
Submit an article Journal homepage
340
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Biotin interference in routine IDS-iSYS immunoassays for aldosterone, renin, insulin-like growth factor 1, growth hormone and bone alkaline phosphatase

Cindy Soendersoe Knudsena Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, DenmarkView further author information
,
Kasper Adelborga Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark;b Department of Clinical Medicine, Aarhus University, Aarhus, Denmark;c Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark;Correspondence[email protected]
View further author information
,
Esben Søndergaardb Department of Clinical Medicine, Aarhus University, Aarhus, Denmark;d Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, DenmarkView further author information
&
Tina Parknera Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark;b Department of Clinical Medicine, Aarhus University, Aarhus, DenmarkView further author information
Pages 6-11 | Received 18 Jun 2021, Accepted 26 Oct 2021, Published online: 03 Dec 2021

References

  • Zempleni J, Mock DM. Biotin biochemistry and human requirements. J Nutr Biochem. 1999;10(3):128–138.
  • Cree BAC, Cutter G, Wolinsky JS, et al. Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Neurol. 2020;19(12):988–997.
  • Li D, Rooney MR, Burmeister LA, et al. Trends in daily use of biotin supplements among US adults, 1999–2016. JAMA. 2020;324(6):605–607.
  • Li D, Ferguson A, Cervinski MA, et al. AACC guidance document on biotin interference in laboratory tests. J Appl Lab Med. 2020;5(3):575–587.
  • Katzman BM, Lueke AJ, Donato LJ, et al. Prevalence of biotin supplement usage in outpatients and plasma biotin concentrations in patients presenting to the emergency department. Clin Biochem. 2018;60:11–16.
  • Trambas CM, Liu KC, Luu H, et al. Further assessment of the prevalence of biotin supplementation and its impact on risk. Clin Biochem. 2019;65:64–65.
  • Sanders A, Gama R, Ashby H, et al. Biotin immunoassay interference: a UK-based prevalence study. Ann Clin Biochem. 2021;58(1):66–69.
  • Ijpelaar A, Beijers A, van Daal H, et al. Prevalence of detectable biotin in The Netherlands in relation to risk on immunoassay interference. Clin Biochem. 2020;83:78–80.
  • The FDA warns that biotin may interfere with lab tests: FDA safety communication. 2017 [accessed 23 March 2021]. Available from: https://www.fda.gov/medical-devices/safety-communications/fda-warns-biotin-may-interfere-lab-tests-fda-safety-communication
  • Piketty ML, Polak M, Flechtner I, et al. False biochemical diagnosis of hyperthyroidism in streptavidin-biotin-based immunoassays: the problem of biotin intake and related interferences. Clin Chem Lab Med. 2017;55(6):780–788.
  • Li D, Radulescu A, Shrestha RT, et al. Association of biotin ingestion with performance of hormone and nonhormone assays in healthy adults. JAMA. 2017; 318(12):1150–1160.
  • CLSI. Interference testing in clinical chemistry. CLSI guideline EP07. 3rd ed. Wayne (PA): Clinical and Laboratory Standards Institute; 2018.
  • Arendt JFH, Hansen AT, Ladefoged SA, et al. Existing data sources in clinical epidemiology: laboratory information system databases in Denmark. Clin Epidemiol. 2020;12:469–475.
  • Livaniou E, Evangelatos GP, Ithakissios DS, et al. Serum biotin levels in patients undergoing chronic hemodialysis. Nephron. 1987;46(3):331–332.
  • Grimsey P, Frey N, Bendig G, et al. Population pharmacokinetics of exogenous biotin and the relationship between biotin serum levels and in vitro immunoassay interference. Int J Pharmacokinet. 2017;2(4):247–256.
  • Peyro Saint Paul L, Debruyne D, Bernard D, et al. Pharmacokinetics and pharmacodynamics of MD1003 (high-dose biotin) in the treatment of progressive multiple sclerosis. Expert Opin Drug Metab Toxicol. 2016;12(3):327–344.
  • Haslam S, Hall C, Penny P, et al. Assessment of biotin interference in four routine IDS iSYS immunoassays. Clin Chim Acta. 2019;/06/01/493:S74.
  • Trambas C, Lu Z, Yen T, et al. Characterization of the scope and magnitude of biotin interference in susceptible roche elecsys competitive and sandwich immunoassays. Ann Clin Biochem. 2018;55(2):205–215.
  • Kit Insert. Immunodiagnostic systems-iSYS renin assay 7 June 2017.
  • Kit Insert. Immunodiagnostic systems-iSYS aldosterone assay 19 May 2015.
  • Kit Insert. Immunodiagnostic systems-iSYS human growth hormone assay 9 May 2019.
  • Kit Insert. Immunodiagnostic systems-iSYS insulin-like growth factor assay 28 March 2019.
  • Kit Insert. Immunodiagnostic systems-iSYS bone alkaline phosphatase assay 27 February 2017.
  • Funder JW, Carey RM, Mantero F, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(5):1889–1916.
  • Subbarayan SK, Fleseriu M, Gordon MB, et al. Serum IGF-1 in the diagnosis of acromegaly and the profile of patients with elevated IGF-1 but normal glucose-suppressed growth hormone. Endocrin Pract. 2012;18(6):817–825.
  • Fleseriu M, Hashim IA, Karavitaki N, et al. Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(11):3888–3921.
  • Mock DM, Nyalala JO, Raguseo RM. A direct streptavidin-binding assay does not accurately quantitate biotin in human urine. J Nutr. 2001;131(8):2208–2214.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.